WO2005016910A1 - ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法 - Google Patents
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法 Download PDFInfo
- Publication number
- WO2005016910A1 WO2005016910A1 PCT/JP2004/012140 JP2004012140W WO2005016910A1 WO 2005016910 A1 WO2005016910 A1 WO 2005016910A1 JP 2004012140 W JP2004012140 W JP 2004012140W WO 2005016910 A1 WO2005016910 A1 WO 2005016910A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- sulfamoyl
- hydrogen atom
- alkyl
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Definitions
- Patent Document 4 International Publication No. 01 Z29026
- Patent Document 11 International Publication No. 02 74767
- Non-Patent Document 2 George Lunn, "The Journal of Organic Chemistry” s (USA), The American Chemical Society, 1992, p. 63 17-6320
- the alkynyl group represented by R1, R4, R7, R10, R13 and R14 is a straight-chain or branched chain such as ethynyl, butynyl, pentynyl, hexynyl, heptynyl, octynyl, noninyl, cyclooctynyl, cyclononinyl, cyclodecynyl, etc. Represents a cyclic alkynyl group having 2 to 20 carbon atoms.
- the aryloxy group represented by R1, R4, R7, R10, R13 and R14 represents phenoxy, naphthyloxy and the like.
- the ureido group represented by R1, R4, R7, R10, R13 and R14 is ureido, N-methylureide, N- (tert-butynole) ureide, N-octylureide, N-hexadecylureide, N-phenylureide , N, N-diethylureide, N, N-dipropylureide, N, N-dihexylureide, N, N-didecylureide, N, N-dioctadecylperide, N, N-diphenylureide, etc. .
- Monosubstituted amino groups such as N-phenylamino and N-naphthylamino; N, N-getylamino N, N-diheptylamino, N, N-dioctylamino N, N-dodecylamino, N, N-octadecylamino, N , N- represents a disubstituted amino group such as diphenylamino.
- R1 and R2, R4 and R5, R7 and R8, R10 and R11, R13 and R14 may form a ring structure
- a ring examples include partially saturated rings such as cyclopentene, cyclohexene, and cyclooctene; aromatic rings such as benzene and naphthalene; and hetero rings such as pyrrole, dihydropyrrole, pyridine, pyran, and dihydropyran. These rings may further have a substituent and are not particularly limited.
- the synthesis method of the present invention relates to a pyridylpyridyl compound represented by the general formula (V) as a starting material.
- a benzyl derivative hereinafter abbreviated as a biviridine derivative
- a benzyl halide or a benzyloxycarbonyl halide in a suitable solvent, and then the resulting intermediate is converted to a palladium catalyst, a platinum catalyst, a ruthenium catalyst.
- the reaction solution was concentrated to dryness, passed through a silica gel column (40 micro, manufactured by DT Baker), eluted with toluene, and the fraction was concentrated to obtain 6.6 g of pale brown crystals.
- the crystals were dissolved in 19 mL of hydrochloric acid, and the reaction solution was refluxed for 3 hours.
- the reaction solution was cooled to room temperature, sodium hydroxide was added until the reaction solution reached pH 13, and the mixture was extracted with chloroform. After the organic layers were combined and dried over anhydrous magnesium sulfate, the inorganic substance was filtered, the obtained organic layer was concentrated, and the precipitated crystals were dried to obtain 2.6 g of a pale yellow oil.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/568,577 US7632950B2 (en) | 2003-08-18 | 2004-08-18 | Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them |
EP20040772101 EP1657240A4 (en) | 2003-08-18 | 2004-08-18 | PYRIDYLTETRAHYDROPYRIDINE, PYRIDYLPIPERIDINE AND METHOD FOR THE PRODUCTION THEREOF |
JP2005513224A JP4866610B2 (ja) | 2003-08-18 | 2004-08-18 | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類 |
US12/576,321 US8530662B2 (en) | 2003-08-18 | 2009-10-09 | Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003294287 | 2003-08-18 | ||
JP2003-294287 | 2003-08-18 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/568,577 A-371-Of-International US7632950B2 (en) | 2003-08-18 | 2004-08-18 | Pyridyltetrahydropyridines and pyridylpiperidines and method of manufacturing them |
US12/576,321 Continuation-In-Part US8530662B2 (en) | 2003-08-18 | 2009-10-09 | Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them |
US12/576,321 Division US8530662B2 (en) | 2003-08-18 | 2009-10-09 | Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005016910A1 true WO2005016910A1 (ja) | 2005-02-24 |
Family
ID=34191025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/012140 WO2005016910A1 (ja) | 2003-08-18 | 2004-08-18 | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法 |
Country Status (4)
Country | Link |
---|---|
US (2) | US7632950B2 (ja) |
EP (2) | EP1657240A4 (ja) |
JP (2) | JP4866610B2 (ja) |
WO (1) | WO2005016910A1 (ja) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2128155A1 (en) | 2008-05-30 | 2009-12-02 | Fujifilm Finechemicals Co. Ltd. | Triazole derivative or salt thereof |
US20100029947A1 (en) * | 2003-08-18 | 2010-02-04 | Fujifilm Finechemicals Co., Ltd | Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them |
US7767677B2 (en) | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
US7777036B2 (en) | 2004-09-20 | 2010-08-17 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
US7829712B2 (en) | 2004-09-20 | 2010-11-09 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
US7919496B2 (en) | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
US8026360B2 (en) | 2004-09-20 | 2011-09-27 | Xenon Pharmaceuticals Inc. | Substituted pyridazines as stearoyl-CoA desaturase inhibitors |
US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
US8541457B2 (en) | 2005-06-03 | 2013-09-24 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
US11780820B2 (en) | 2017-03-13 | 2023-10-10 | Sumitomo Pharma Co., Ltd. | 2,6-disubstituted pyridine derivative |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2114955E (pt) | 2006-12-29 | 2013-04-18 | Rigel Pharmaceuticals Inc | Triazoles substituídos com arilo bicíclico em ponte ou heteroarilo bicíclico em ponte úteis como inibidores de axl |
PE20090422A1 (es) | 2007-04-27 | 2009-04-18 | Purdue Pharma Lp | Derivados de piperidina, piperazina o tetrahidropiridilo como antagonistas de trpv1 |
EP2014656A3 (en) * | 2007-06-11 | 2011-08-24 | High Point Pharmaceuticals, LLC | New heteocyclic h3 antagonists |
WO2010013849A1 (ja) * | 2008-08-01 | 2010-02-04 | 日本ケミファ株式会社 | Gpr119作動薬 |
ES2439767T3 (es) * | 2008-08-01 | 2014-01-24 | Purdue Pharma Lp | Compuestos de tetrahidropiridinilo y dihidropirrolilo y uso de los mismos |
PE20141531A1 (es) | 2011-06-22 | 2014-10-23 | Purdue Pharma Lp | Antagonistas de trpv1 que incluyen sustituyentes dihidroxi y sus usos |
GB201209587D0 (en) | 2012-05-30 | 2012-07-11 | Takeda Pharmaceutical | Therapeutic compounds |
GB201320905D0 (en) * | 2013-11-27 | 2014-01-08 | Takeda Pharmaceutical | Therapeutic compounds |
US10459759B2 (en) * | 2015-08-26 | 2019-10-29 | Netapp, Inc. | Migration between CPU cores |
US9971089B2 (en) | 2015-12-09 | 2018-05-15 | Intel Corporation | Chip-to-chip interconnect with embedded electro-optical bridge structures |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001062742A1 (en) * | 2000-02-21 | 2001-08-30 | Astrazeneca Ab | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
JP2002518327A (ja) * | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | セロトニン再取り込みインヒビター |
JP2002518386A (ja) * | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | ヘテロアリール化合物の製造 |
WO2003099266A2 (en) * | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003306A1 (en) * | 1993-07-22 | 1995-02-02 | E.I. Du Pont De Nemours And Company | Arthropodicidal azacyclic heterocycles |
PL313973A1 (en) | 1993-10-12 | 1996-08-05 | Du Pont Merck Pharma | 1 n-alkyl-n-arylopyrimidin amines and their derivatives |
FR2736053B1 (fr) | 1995-06-28 | 1997-09-19 | Sanofi Sa | Nouvelles 1-phenylalkyl-1,2,3,6-tetrahydropyridines |
US6159990A (en) | 1997-06-18 | 2000-12-12 | Synaptic Pharmaceutical Corporation | Oxazolidinones as α1A receptor antagonists |
ES2179515T3 (es) * | 1997-07-14 | 2003-01-16 | Suntory Ltd | Metodo para producir derivados de 3-halogeno-1,4-benzoxazepina sustituidos en posicion 4 y sus sales. |
JP2001512724A (ja) | 1997-08-05 | 2001-08-28 | メルク エンド カムパニー インコーポレーテッド | α1aアドレナリン受容体拮抗薬 |
CA2325472A1 (en) | 1998-03-25 | 1999-09-30 | Graham S. Poindexter | Imidazolone anorectic agents: iii. heteroaryl derivatives |
JP3032980B1 (ja) | 1999-06-14 | 2000-04-17 | 三協化学株式会社 | 2―ピリジルピリジン誘導体の製造方法 |
EP1194151A4 (en) * | 1999-06-23 | 2003-01-15 | Merck & Co Inc | ANTAGONISTS OF THE INTEGRIN RECEPTORS |
EP1065207A1 (en) * | 1999-07-02 | 2001-01-03 | Aventis Pharma Deutschland GmbH | Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
US6521630B1 (en) * | 1999-08-31 | 2003-02-18 | Pfizer Inc. | Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof |
GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
NZ518112A (en) | 1999-10-22 | 2003-11-28 | Sanofi Synthelabo | Phenyl- and pyridyl-tetrahydropyridines having TNF inhibiting activity |
EP1224185B1 (en) * | 1999-10-27 | 2005-11-30 | Novartis AG | Thiazole and imidazo[4,5-b]pyridine compounds and their pharmaceutical use |
JP2001261646A (ja) | 2000-03-17 | 2001-09-26 | Sankio Chemical Co Ltd | ピリジン誘導体の製造法 |
JP2001261647A (ja) | 2000-03-22 | 2001-09-26 | Sankio Chemical Co Ltd | ピリジン誘導体の製造方法 |
GB0010757D0 (en) | 2000-05-05 | 2000-06-28 | Astrazeneca Ab | Chemical compounds |
GB0028583D0 (en) | 2000-11-23 | 2001-01-10 | Merck Sharp & Dohme | Therapeutic compounds |
JP2004527511A (ja) * | 2001-03-15 | 2004-09-09 | アストラゼネカ・アクチエボラーグ | メタロプロテイナーゼ阻害剤 |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
AU2002306848A1 (en) * | 2001-03-23 | 2002-10-08 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease with piperidin derivates |
US20030171368A1 (en) * | 2002-02-06 | 2003-09-11 | Werner Seitz | Pyrimidinonesulfamoylureas` |
AUPS137402A0 (en) * | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
MXPA04010555A (es) * | 2002-04-25 | 2005-02-17 | Pharmacia Corp | Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa. |
GB0209715D0 (en) * | 2002-04-27 | 2002-06-05 | Astrazeneca Ab | Chemical compounds |
CA2486564A1 (en) * | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
US20060009461A1 (en) | 2002-05-23 | 2006-01-12 | Bhatia Pramila A | Acetamides and benzamides that are useful in treating sexual dysfunction |
DE10306250A1 (de) * | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
EP1657240A4 (en) * | 2003-08-18 | 2009-04-08 | Fujifilm Finechemicals Co Ltd | PYRIDYLTETRAHYDROPYRIDINE, PYRIDYLPIPERIDINE AND METHOD FOR THE PRODUCTION THEREOF |
-
2004
- 2004-08-18 EP EP20040772101 patent/EP1657240A4/en not_active Withdrawn
- 2004-08-18 EP EP11191197A patent/EP2426120A1/en not_active Withdrawn
- 2004-08-18 WO PCT/JP2004/012140 patent/WO2005016910A1/ja active Application Filing
- 2004-08-18 US US10/568,577 patent/US7632950B2/en not_active Expired - Fee Related
- 2004-08-18 JP JP2005513224A patent/JP4866610B2/ja not_active Expired - Fee Related
-
2009
- 2009-10-09 US US12/576,321 patent/US8530662B2/en not_active Expired - Fee Related
-
2010
- 2010-10-18 JP JP2010234080A patent/JP5216065B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002518327A (ja) * | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | セロトニン再取り込みインヒビター |
JP2002518386A (ja) * | 1998-06-19 | 2002-06-25 | イーライ・リリー・アンド・カンパニー | ヘテロアリール化合物の製造 |
WO2001062742A1 (en) * | 2000-02-21 | 2001-08-30 | Astrazeneca Ab | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
WO2003099266A2 (en) * | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
Non-Patent Citations (3)
Title |
---|
CARELLI V. ET AL.: "Alcuni derivati gama-piridin-e gama-chinolin-piperidinici", ANNALI DI CHIMICA, vol. 49, 1959, pages 709 - 719, XP002119487 * |
RUTJES F.P.J.T. ET AL.: "Selective azetidine and tetrahydropyridine formation via Pd-catalyzed cyclizations of allene-substituted amines and amino acids", ORG. LETT., vol. 1, no. 5, 1999, pages 717 - 720, XP002995678 * |
See also references of EP1657240A4 * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100029947A1 (en) * | 2003-08-18 | 2010-02-04 | Fujifilm Finechemicals Co., Ltd | Pyridyltetrahydropyridines and Pyridylpiperidines, and Method of Manufacturing Them |
US8530662B2 (en) * | 2003-08-18 | 2013-09-10 | Fujifilm Finechemicals Co., Ltd | Pyridyltetrahydropyridines and pyridylpiperidines, and method of manufacturing them |
US7767677B2 (en) | 2004-09-20 | 2010-08-03 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
US7777036B2 (en) | 2004-09-20 | 2010-08-17 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as therapeutic agents |
US7829712B2 (en) | 2004-09-20 | 2010-11-09 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase |
US7919496B2 (en) | 2004-09-20 | 2011-04-05 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes |
US7951805B2 (en) | 2004-09-20 | 2011-05-31 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase |
US8026360B2 (en) | 2004-09-20 | 2011-09-27 | Xenon Pharmaceuticals Inc. | Substituted pyridazines as stearoyl-CoA desaturase inhibitors |
US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
US8541457B2 (en) | 2005-06-03 | 2013-09-24 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
EP2128155A1 (en) | 2008-05-30 | 2009-12-02 | Fujifilm Finechemicals Co. Ltd. | Triazole derivative or salt thereof |
US11780820B2 (en) | 2017-03-13 | 2023-10-10 | Sumitomo Pharma Co., Ltd. | 2,6-disubstituted pyridine derivative |
Also Published As
Publication number | Publication date |
---|---|
US8530662B2 (en) | 2013-09-10 |
JP4866610B2 (ja) | 2012-02-01 |
JP2011042671A (ja) | 2011-03-03 |
EP1657240A4 (en) | 2009-04-08 |
US20100029947A1 (en) | 2010-02-04 |
EP1657240A1 (en) | 2006-05-17 |
JPWO2005016910A1 (ja) | 2006-10-12 |
EP2426120A1 (en) | 2012-03-07 |
JP5216065B2 (ja) | 2013-06-19 |
US7632950B2 (en) | 2009-12-15 |
US20070093528A1 (en) | 2007-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005016910A1 (ja) | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法 | |
CN109020881B (zh) | 一种阿帕替尼的制备方法 | |
CN103080072A (zh) | 制备可用于生产nep抑制剂的中间体的新方法 | |
KR100691735B1 (ko) | 4-아미노메틸-3-알콕시이미노피롤리딘 메탄설폰산염의신규한 제조 방법 | |
KR101372389B1 (ko) | 이바브라딘 및 이의 약제학적으로 허용되는 산과의 부가염을 합성하는 방법 | |
CN110483487A (zh) | 一种2-硫甲基吡唑嘧啶酮类化合物、其制备方法、药物组合物及应用 | |
KR20040091720A (ko) | N1-(2'-피리딜)-1,2-프로판디아민 설팜산의 제조방법 및생물학적 활성 피페라진 합성시의 이의 용도 | |
KR20220018494A (ko) | 피롤리딘 화합물 | |
KR101012134B1 (ko) | 이마티니브 및 이마티니브 메실레이트염의 제조방법 | |
JP3018185B1 (ja) | キナゾリン誘導体又はその塩の製造方法 | |
GB2557867A (en) | New synthetic path to vortioxetine salts | |
US10487074B2 (en) | Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form | |
US6316627B1 (en) | Process for the preparation of flecainide | |
JPH06184074A (ja) | 1−アルコキシナフタレン−2−カルボキサミド誘導体、その製法並びに該誘導体を含有する医薬組成物 | |
CA2825925A1 (en) | Method for producing di(arylamino)aryl compound and synthetic intermediate therefor | |
CZ294344B6 (cs) | Způsob výroby arylamidů heteroaromatických karboxylových kyselin | |
US6150417A (en) | Phenoxyethylamine derivatives, method of preparation application as medicine and pharmaceutical compositions containing same | |
US20070249847A1 (en) | Method for Producing Acetamidopyrrolidine Derivatives and Intermediate Compounds Thereof | |
US9908858B2 (en) | Method for the synthesis of a hydrazine that can be used in the treatment of the papilloma virus | |
JP2007119399A (ja) | N−保護−2−アミノペンタン酸誘導体の製造方法 | |
CN112778193A (zh) | 一种(s)-3-(4-氯苯基)-哌啶的合成方法 | |
KR20190013555A (ko) | 프로테인 카이네이즈에 대한 선택적 억제제의 합성에 유용한 중간체 및 이의 제조방법 | |
JP2005112804A (ja) | インドリルメチルアミノピロリジン誘導体およびその製造法 | |
JPH09227532A (ja) | 2−ニトロイミノヘキサヒドロ−1,3,5−トリアジン類の製造法 | |
KR20090053058A (ko) | 신규 광학 분할제 및 이를 이용하여 광학 이성질체를분리하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005513224 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004772101 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004772101 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007093528 Country of ref document: US Ref document number: 10568577 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10568577 Country of ref document: US |